View Cart  

FDA Hosts Drug Development Meeting for Neurologic Manifestations of Inborn Metabolism Errors

The meeting is one step toward fulfilling the agency’s patient-focused drug development requirements under PDUFA V. Read More

BD Launches Near Patient CD4 Counter System for HIV Patients

BD Biosciences is launching its FACSPresto Near Patient CD4 Counter System in CE mark countries after receiving authorization March 28, the company said Thursday. Read More
The Solutions Center